Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Closes $370M Acquisition of JRH Biosciences

NEW YORK, March 1 (GenomeWeb News) - Sigma-Aldrich today announced the completion of its previously announced acquisition of JRH Biosciences.

 

The acquisition, which was originally announced on Jan. 18, is worth $370 million.

 

JRH, headquartered in Lenexa, Kan., supplies cell culture and sera products to the biopharmaceutical industry. It had approximately $150 million in sales in 2004, and was expecting 10-percent growth in sales in 2005, Sigma said.

 

Ten months of JRH's operating results will be added to Sigma-Aldrich's 2005 performance, Sigma said.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.